Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

The weight-loss drug boom has become one of the internet's biggest scams
Tags Drugs Crime Meta Platforms Inc
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Amgen Inc Bristol/Myers Squibb Co Novo Nordisk A/S
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Companies US: News Social issues
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags DICK'S Sporting Goods Inc Technology Earnings
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Biotechnology US: News Companies
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Novartis AG Health care industry LILLY DRN
From CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
Tags Coinbase Global Inc Apple Inc Mad Money
From CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
Tags U/S/ Markets PepsiCo Inc/ Business News
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Business Pharmaceuticals LILLY DRN
From CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
Tags Tesla Inc Media U/S/ Markets
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Health & Science Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Jim Cramer says CEOs must properly explain the bad news in every quarter
Tags Markets NVIDIA Corp Stock Picks
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
Tags LILLY DRN Business Pharmaceuticals
From CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
Tags Markets Starbucks Corp Visa Inc
From CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
Tags Biotech and Pharmaceuticals Health care industry Earnings
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags KB Home Microsoft Corp New York Times Co
From CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
Tags Business News Caterpillar Inc Investing
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Health care industry Diabetes Medical research
From CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
Tags stocks Stock markets LILLY DRN
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Amazon/com Inc Social issues Health & Science
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
Tags Exchange/traded funds U/S/ Markets Overview Wall Street
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Social issues Abbott Laboratories Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Tags Social issues Business News Health & Science
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Pharmaceuticals Zealand Pharma A/S LILLY DRN
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Stock markets stocks Tesla Inc
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Investment strategy Politics Stellantis NV
From CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
Tags Business Health care industry Science
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.